Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Carcinoma, Transitional Cell; Urinary Bladder Neoplasms Phase 1 ClinicalTrials
Carcinoma; Urinary Bladder Diseases; Urologic Diseases Phase 1/Phase 2 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1 ClinicalTrials
CONTENTS